252 - Inhaling Insight: Advancements in Respiratory Viral Infections

Moderator(s)

• 

  Jackrapong Bruminhent, MD, FIDSA

  Associate Professor of Medicine
  Faculty of Medicine Ramathibodi Hospital, Mahidol University
  Bangkok, Krung Thep, Thailand
• 

  Trish Perl, MD, MSc (she/her/hers)

  Professor and Associate Dean
  Internal Medicine
  University of Texas Southwestern Medical Center
  Dallas, TX, United States

Presentations:

• 1:45 PM – 2:03 PM US PT

  Safety and Immunogenicity of Coadministered Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine With and Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age
  

  Co-Author: Joel Neutel, MD – Orange County Research Center

  Presenting Author: Rahsan Erdem, MD (she/her/hers) – Vaccine Research and Development, Pfizer Inc

  Co-Author: Qin Jiang, PhD – Pfizer

  Co-Author: Kevin Cannon, MD – Accellacare

  Co-Author: Helen Stacey, M.D., MPH – Diablo Clinical Research

  Co-Author: Ryan Newton, BSC/MBA – Vaccine Research and Development, Pfizer Ltd

  Co-Author: Emily A. Gomme, Ph.D. – Pfizer

  Co-Author: Wen Li, PhD – Pfizer Vaccine Clinical Research

  Co-Author: Federico Mensa, MD – BioNTech

  Co-Author: Ozlem Tureci, MD – BioNTech

  Co-Author: Ugur Sahin, MD – BioNTech

  Co-Author: Kena A. Swanson, Ph.D. – Pfizer

  Co-Author: Iona Munjal, MD (she/her/hers) – Pfizer Inc

  Co-Author: David Cooper, PhD – Pfizer

  Co-Author: Kenneth Koury, PhD – Pfizer

  Co-Author: Annaliesa S. Anderson, PhD – Pfizer

  Co-Author: Alejandra C. Gurtman, M.D. – Pfizer

  Co-Author: Nicholas Kitchin, MD – Pfizer Inc
• 2:03 PM – 2:21 PM US PT

  The Burden of RSV Infections Among Nursing Home Residents, Monroe County, NY, October 2022 to April 2023
  

  Presenting Author: Kevin Popham, MPH (he/him/his) – Universirty of Rochester

  Co-Author: Katherine St George, n/a – University of Rochester School of Medicine and Dentistry

  Co-Author: Christina B. Felsen, MPH – University of Rochester

  Co-Author: Ghinwa Dumyati, MD – New York Emerging Infections Program and University of Rochester Medical Center

  Co-Author: Brenda L. Tesini, MD – University of Rochester
• 2:21 PM – 2:39 PM US PT

  CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model
  

  Co-Author: Ozlem Equils, MD – Cidara Therapeutics

  Co-Author: Shawn Flanagan, PhD (he/him/his) – Cidara Therapeutics

  Co-Author: Sy-Shi Wang, Ph.D. – Janssen Pharmaceutical

  Co-Author: Johan Vingerhoets, PhD – Janssen Pharmaceutica NV, Infectious Diseases and Vaccines

  Co-Author: Wilbert van Duijnhoven, n/a – Janssen Pharmaceutica NV

  Co-Author: Alex James Mann, MSc – hVIVO

  Co-Author: Roxana E. Rojas, M.D., Ph.D. – Janssen Research & Development

  Presenting Author: Taylor Sandison, MD, MPH (he/him/his) – Cidara Therapeutics
• 2:39 PM – 2:59 PM US PT

  Early Post-Marketing Safety Surveillance for the Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA)
  

  Co-Author: Céline Verheust, PhD – GSK, Wavre, Belgium

  Presenting Author: Quentin Deraedt, PhD – GSK, Wavre, Belgium

  Co-Author: Philip Bryan, PhD – GSK, London, United Kingdom